PRMT5 and colorectal carcinoma: We therefore examined the effect of pharmacological inhibition of PRMT5 activity using a small molecule active site inhibitor, T1-44, which is an effective and selective inhibitor of PRMT5 (supplementary Fig. 1A,11) in murine CT26 colorectal cancer (CRC) cells.